Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Jan 08, 2021 2:27pm
200 Views
Post# 32255635

RE:RE:RE:RE:RE:RE:Canadian Small/Micro Cap Top picks for 2021

RE:RE:RE:RE:RE:RE:Canadian Small/Micro Cap Top picks for 2021
SunsetGrill wrote: NO - not a big difference at all. AND they dont have enough money for 12-18 mos.

Such a big difference - how come NO sales??

Banderas1209 wrote: The VMS3.0 is not out for 10 years!

they exist 10 years and you know the first 2 where far from great and user friendly

VMS 3.0 is really operational since 2020

big difference


Either way if nothing happens the next 12-18 months I will give the credits but I still believe in it




 

'Correct.
'They had cash on hand of ~295k in September, and IF they could convert AR etc 400k
Based on a burn rate of 80k- they would be expected to be insolvent by next month-unless they get more cash.
'This is based on published financials.

"The Company’s use of cash at present occurs, and in the future will occur, principally in two areas, namely, funding of its general and administrative expenditures and funding of its development and commercialization activities. For fiscal 2020, the Company’s expected operating expenses are estimated to average $80,000 per month for recurring operating costs. The Company has no development commitments on its property interests over the next 12 months. Management may reassess its planned expenditures based on the Company’s working capital resources, the scope work required to advance exploration on its projects and the overall condition of the financial markets.
   Page |12
 
   VENTRIPOINT DIAGNOSTICS LTD.
Management’s Discussion & Analysis – Quarterly Highlights Three and Nine Months Ended September 30, 2020
Dated November 30, 2020
The Company’s working capital deficiency of $1,462,507 at September 30, 2020, (December 31, 2019 - working capital deficiency of $1,739,658), and is not sufficient to satisfy current liabilities and general and administrative costs for it to continue operations for the twelve-month period ending September 30, 2020"
SEDAR.COM
<< Previous
Bullboard Posts
Next >>